NeoPharm gains on brain cancer data

NEOL was up $2.99 (38%) to $10.80 on 1.6 million shares on Monday

Read the full 131 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE